Neogen (NEOG) Stock Price, News & Analysis

Company Overview

Neogen Corporation is a global provider of food safety and animal safety products and services. The company develops diagnostic tests, laboratory products, and related solutions that help customers detect foodborne pathogens, allergens, toxins, residues, and other contaminants throughout the food production process.

Its food safety portfolio includes test kits, culture media, molecular testing systems, sanitation monitoring products, and laboratory supplies used by food manufacturers, processors, retailers, and regulatory organizations. Neogen also provides animal safety products, including veterinary instruments, animal care products, biosecurity solutions, and diagnostic and genomic services for livestock, companion animals, and agricultural operations.

Founded in 1982 and headquartered in Lansing, Michigan, Neogen serves customers in North America and international markets through a global sales, distribution, and manufacturing network. The company expanded its food safety business through the acquisition of 3M’s Food Safety business, completed in 2022, adding established testing products and capabilities to its portfolio.

Key Stats

• Today's Range: $12.26 to $13.22
• 50-Day Range: $9.19 to $13.98
• 52-Week Range: $5.37 to $14.26
• Volume: 1.08 million shs
• Average Volume: 2.88 million shs
• Market Capitalization: $2.69 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $12.67
• Consensus Rating: Hold

Neogen Stock Analysis - MarketRank™

Neogen scored higher than 35% of companies evaluated by MarketBeat, and ranked 705th out of 885 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.8 / 5
• Analyst Rating: Hold

Consensus Rating

Neogen has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.

Upside/Downside

The consensus price target for Neogen is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Neogen has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 18.52%

Earnings Growth

Earnings for Neogen are expected to grow by 18.52% in the coming year, from $0.27 to $0.32 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Neogen is -433.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Neogen is -433.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Neogen has a PEG Ratio of 4.56. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Neogen has a P/B Ratio of 1.35. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.14% of the float of Neogen has been sold short.

Short Interest Ratio / Days to Cover

Neogen has a short interest ratio ("days to cover") of 4.53.

Change versus previous month

Short interest in Neogen has recently increased by 5.54%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Neogen does not currently pay a dividend.

Dividend Growth

Neogen does not have a long track record of dividend growth.

News and Social Media

• Score: 2.5 / 5
• News Sentiment: 0.03

News Sentiment

Neogen has a news sentiment score of 0.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.42 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 17 news articles for Neogen this week, compared to 6 articles on an average week.

Search Interest

3 people have searched for NEOG on MarketBeat in the last 30 days.

MarketBeat Follows

Only 1 people have added Neogen to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 2.2 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Neogen insiders have bought more of their company's stock than they have sold. Specifically, they have bought $4,370.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

0.46% of the stock of Neogen is held by insiders.

Percentage Held by Institutions

96.73% of the stock of Neogen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 7/30/2026
• Today: 10/06/2026
• Next Earnings (Confirmed): 10/06/2026
• Investor Day 2026: 10/07/2026
• Fiscal Year End: 5/31/2027

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Supplies
• Current Symbol: NASDAQ:NEOG
• CIK: 711377
• Web: www.neogen.com
• Phone: (517) 372-9200
• Fax: 517-372-2006
• Employees: 1,257
• Year Founded: 1982

Price Target and Rating

• Average Price Target for Neogen: $12.67
• High Price Target: $14.00
• Low Price Target: $10.00
• Potential Upside/Downside: +2.7%
• Consensus Rating: Hold
• Rating Score (0-4): 2.40
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.03)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 45.69
• P/E Growth: 4.56
• Net Income: -$7.90 million
• Net Margins: -0.91%
• Pretax Margin: -1.03%
• Return on Equity: 2.78%
• Return on Assets: 1.74%

Debt

• Debt-to-Equity Ratio: 0.38
• Current Ratio: 3.82
• Quick Ratio: 2.91

Sales & Book Value

• Annual Sales: $870.40 million
• Price / Sales: 3.09
• Cash Flow: $0.86 per share
• Price / Cash Flow: 14.41
• Book Value: $9.61 per share
• Price / Book: 1.28

Miscellaneous

• Outstanding Shares: 218,106,000
• Free Float: 217,103,000
• Market Cap: $2.69 billion
• Optionable: Optionable
• Beta: 1.79